Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Diabetes Care
Saved in:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
American Diabetes Association
2023
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/246027 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-246027 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-2460272023-11-17T03:53:11Z Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis Anantharaman, Vathsala Rossing, Peter Anker, Stefan D Filippatos, Gerasimos Pitt, Bertram Ruilope, Luis M Birkenfeld, Andreas L McGill, Janet B Rosas, Sylvia E Joseph, Amer Gebel, Martin Roberts, Luke Scheerer, Markus F Bakris, George L Agarwal, Rajiv MEDICINE Diabetes Care 2023-11-17T03:39:16Z 2023-11-17T03:39:16Z 2022-12-01 2023-11-17T03:26:27Z Article Anantharaman, Vathsala, Rossing, Peter, Anker, Stefan D, Filippatos, Gerasimos, Pitt, Bertram, Ruilope, Luis M, Birkenfeld, Andreas L, McGill, Janet B, Rosas, Sylvia E, Joseph, Amer, Gebel, Martin, Roberts, Luke, Scheerer, Markus F, Bakris, George L, Agarwal, Rajiv (2022-12-01). Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis. Diabetes Care. ScholarBank@NUS Repository. 0149-5992 1935-5548 https://scholarbank.nus.edu.sg/handle/10635/246027 American Diabetes Association Elements |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
description |
Diabetes Care |
author2 |
MEDICINE |
author_facet |
MEDICINE Anantharaman, Vathsala Rossing, Peter Anker, Stefan D Filippatos, Gerasimos Pitt, Bertram Ruilope, Luis M Birkenfeld, Andreas L McGill, Janet B Rosas, Sylvia E Joseph, Amer Gebel, Martin Roberts, Luke Scheerer, Markus F Bakris, George L Agarwal, Rajiv |
format |
Article |
author |
Anantharaman, Vathsala Rossing, Peter Anker, Stefan D Filippatos, Gerasimos Pitt, Bertram Ruilope, Luis M Birkenfeld, Andreas L McGill, Janet B Rosas, Sylvia E Joseph, Amer Gebel, Martin Roberts, Luke Scheerer, Markus F Bakris, George L Agarwal, Rajiv |
spellingShingle |
Anantharaman, Vathsala Rossing, Peter Anker, Stefan D Filippatos, Gerasimos Pitt, Bertram Ruilope, Luis M Birkenfeld, Andreas L McGill, Janet B Rosas, Sylvia E Joseph, Amer Gebel, Martin Roberts, Luke Scheerer, Markus F Bakris, George L Agarwal, Rajiv Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis |
author_sort |
Anantharaman, Vathsala |
title |
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis |
title_short |
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis |
title_full |
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis |
title_fullStr |
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis |
title_full_unstemmed |
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis |
title_sort |
finerenone in patients with chronic kidney disease and type 2 diabetes by sodium-glucose cotransporter 2 inhibitor treatment: the fidelity analysis |
publisher |
American Diabetes Association |
publishDate |
2023 |
url |
https://scholarbank.nus.edu.sg/handle/10635/246027 |
_version_ |
1783955466324279296 |